Literature DB >> 83966

Characterization of a leukemic cell line of the pre-B phenotype.

R Hurwitz, J Hozier, T LeBien, J Minowada, K Gajl-Peczalska, I Kubonishi, J Kersey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 83966     DOI： 10.1002/ijc.2910230206

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  59 in total

1.  National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing.

Authors:  Min H Kang; Malcolm A Smith; Christopher L Morton; Nino Keshelava; Peter J Houghton; C Patrick Reynolds
Journal:  Pediatr Blood Cancer       Date:  2010-10-04       Impact factor: 3.167

2.  The HoxC4 homeodomain protein mediates activation of the immunoglobulin heavy chain 3' hs1,2 enhancer in human B cells. Relevance to class switch DNA recombination.

Authors:  Edmund C Kim; Christopher R Edmonston; Xiaoping Wu; András Schaffer; Paolo Casali
Journal:  J Biol Chem       Date:  2004-07-13       Impact factor: 5.157

3.  Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies.

Authors:  Patrick A Zweidler-McKay; Yiping He; Lanwei Xu; Carlos G Rodriguez; Fredrick G Karnell; Andrea C Carpenter; Jon C Aster; David Allman; Warren S Pear
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

4.  The ubiquitous octamer-binding protein(s) is sufficient for transcription of immunoglobulin genes.

Authors:  D G Johnson; L Carayannopoulos; J D Capra; P W Tucker; J H Hanke
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

5.  Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria.

Authors:  David Hermanson; Sadiya N Addo; Anna A Bajer; Jonathan S Marchant; Sonia Goutam Kumar Das; Balasubramanian Srinivasan; Fawaz Al-Mousa; Francesco Michelangeli; David D Thomas; Tucker W Lebien; Chengguo Xing
Journal:  Mol Pharmacol       Date:  2009-06-26       Impact factor: 4.436

6.  Mutations to Ku reveal differences in human somatic cell lines.

Authors:  Kazi R Fattah; Brian L Ruis; Eric A Hendrickson
Journal:  DNA Repair (Amst)       Date:  2008-04-01

7.  Epitope specificity of the anti-(B cell lymphoma) monoclonal antibody, LL2.

Authors:  R Stein; E Belisle; H J Hansen; D M Goldenberg
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

8.  Leukemia-derived exosomes and cytokines pave the way for entry into the brain.

Authors:  Ichiko Kinjyo; Denis Bragin; Rachel Grattan; Stuart S Winter; Bridget S Wilson
Journal:  J Leukoc Biol       Date:  2019-01-31       Impact factor: 4.962

9.  BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.

Authors:  Christopher J Ott; Nadja Kopp; Liat Bird; Ronald M Paranal; Jun Qi; Teresa Bowman; Scott J Rodig; Andrew L Kung; James E Bradner; David M Weinstock
Journal:  Blood       Date:  2012-08-17       Impact factor: 22.113

10.  A comparison between protein profiles of B cell subpopulations and mantle cell lymphoma cells.

Authors:  Henrik Stranneheim; Lukas M Orre; Janne Lehtiö; Jenny Flygare
Journal:  Proteome Sci       Date:  2009-11-23       Impact factor: 2.480
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.